Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

NMR vs GAINZ: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

NMR Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 7–3 Matrix Metrics)

NMR Overall Winner 6-Pillar Tally: NMR 5 – 0 GAINZ (1 Tie) Matrix Metrics: NMR 7 – 3 GAINZ

As of Nov 20, 2026, Nomura Holdings, Inc (NMR) is the stronger overall head-to-head candidate over Gladstone Investment Corporation 4.875% Notes due 2028 (GAINZ) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). NMR carries a Unified Composite Score of 35.0/100 (SELL) at $8.51 (11.4x Forward P/E, 25.1% operating margin), whereas GAINZ carries 51.8/100 (HOLD) at $24.12 (N/M Forward P/E, 0.0% operating margin).

  • Composite vs. Pillar Nuance: While GAINZ currently prints a higher short-term Unified Composite Score (51.8/100 HOLD vs. NMR 35.0/100 SELL), NMR captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (25.1% vs. 0.0% operating margin) and revenue trajectory (+17.9% vs. +0.0% YoY).
  • Technical & Structure Timing Caution: NMR is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.4); meanwhile GAINZ trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 50.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About NMR vs GAINZ
NMR NYSE Head-to-Head Winner
Nomura Holdings, Inc
Security Brokers, Dealers & Flotation Companies
$8.51
-5.86% 1D
Market Cap $26.4B
TTM Revenue $14.9B
Forward P/E 11.4x
Beta / 30D Vol 1.04β · 34% Vol
Unified Composite Score
35.0 / 100 SELL
Tech 13.0 Fund 35.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -3.0%), weak momentum, RSI 30
RSI-14: 30.4 · SMA20: $9.38 · SMA50: $9.58
GAINZ NASDAQ
Gladstone Investment Corporation 4.875% Notes due 2028
Institutional Equity
$24.12
-0.25% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.00β · 3% Vol
Unified Composite Score
51.8 / 100 HOLD
Tech 50.0 Fund 57.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 50
RSI-14: 50.1 · SMA20: $24.09 · SMA50: $24.15

6-Pillar Scorecard Institutional Category Breakdown (NMR 5 – 0 GAINZ)

Columns: Metric · NMR · GAINZ
1. Valuation Multiples NMR
Forward P/E 11.4x N/M
Trailing P/E 10.4x N/M
PEG Ratio 0.81x N/M
EV / Revenue 1.8x N/M
2. Growth & Scale NMR
Revenue Growth (YoY) +17.9% +0.0%
Earnings Growth (YoY) +13.6% +0.0%
TTM Revenue (USD) $14.9B N/A
Market Cap $26.4B N/A
3. Profitability & Quality NMR
Gross Margin 77.4% N/A
Operating Margin 25.1% 0.0%
Net Profit Margin 17.1% 0.0%
Return on Equity (ROE) 11.5% 0.0%
4. Balance Sheet & Cash Flow NMR
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage $8.17 Book/Sh · 11.5% ROE 0.0% ROE
Dividend Yield 1.66% None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 30.7% (<1st %ile) N/A (N/A)
Put/Call OI Skew Thin ADR Chain N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat NMR
OpEx & R&D Intensity 52.3% of Rev ($7.77B) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Capital Markets Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: NMR (7) vs GAINZ (3)
Institutional Metric NMR GAINZ Criterion Row Edge
Market Capitalization
Scale
$26.4B N/A Larger Scale NMR
Trailing P/E Ratio
Valuation
10.4x N/M Lower Multiple NMR
Forward P/E Ratio
Valuation
11.4x N/M Lower Multiple NMR
Revenue Growth (YoY)
Growth
+17.9% +0.0% Higher Growth NMR
Operating Margin (TTM)
Profitability
25.1% 0.0% Higher Margin NMR
Net Profit Margin
Profitability
17.1% 0.0% Higher Margin NMR
Return on Equity (ROE)
Capital Efficiency
11.5% 0.0% Higher ROE NMR
52-Week Range Position
Momentum
40% ($7–$11) 55% ($24–$24) Stronger Trend GAINZ
Beta / 30D Volatility
Risk Regime
1.04β · 34% Vol 0.00β · 3% Vol Lower Realized Risk GAINZ
Unified Institutional Score
Composite Signal
35.0 / 100 (SELL) 51.8 / 100 (HOLD) Higher Composite GAINZ
Trailing 12M Revenue (USD)
Operating Scale
$14.9B N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
77.4% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.81x PEG · 1.8x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($8.17 Book/Sh · 11.5% ROE) N/A (0.0% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon GAINZ +8.04 pp
NMR: -7.7% · GAINZ: +0.34%
3M Horizon GAINZ +13.26 pp
NMR: -13.34% · GAINZ: -0.08%
6M Horizon NMR +7.89 pp
NMR: +7.72% · GAINZ: -0.17%
1Y Horizon NMR +20.84 pp
NMR: +21.92% · GAINZ: +1.08%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NMR vs GAINZ. Trailing 12-month operating profitability (NMR 25.1% vs GAINZ 0.0%) and valuation multiples (NMR 11.4x vs GAINZ N/M Forward P/E) are benchmarked directly in Pillar 4 below.

NMR ADR TTM Benchmark FX-Normalized USD
TTM Revenue$14.9B
Gross Margin77.4%
Op. Margin25.1%
ROE / Fwd P/E11.5% · 11.4x
GAINZ ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E0.0% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
NMR UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 30.7%
IV Percentile <1st %ile
Put/Call OI Skew Thin ADR Chain
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact NMR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
GAINZ UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact GAINZ Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
NMR Moat Profile Scale & Operating Efficiency Moat
Capital Markets Operator
Competes within the Capital Markets value chain with $26.4B market capitalization and 25.1% operating margin.
OpEx & R&D Reinvestment 52.3% of Rev ($7.77B)
90D Engineering Disclosures 0 Published
GAINZ Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ NMR vs GAINZ Key Questions & Quantitative Answers

As of Nov 20, 2026, Nomura Holdings, Inc (NMR) is the stronger overall head-to-head candidate over Gladstone Investment Corporation 4.875% Notes due 2028 (GAINZ) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). NMR carries a Unified Composite Score of 35.0/100 (SELL) at $8.51 (11.4x Forward P/E, 25.1% operating margin), whereas GAINZ carries 51.8/100 (HOLD) at $24.12 (N/M Forward P/E, 0.0% operating margin). Composite vs. Pillar Nuance: While GAINZ currently prints a higher short-term Unified Composite Score (51.8/100 HOLD vs. NMR 35.0/100 SELL), NMR captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (25.1% vs. 0.0% operating margin) and revenue trajectory (+17.9% vs. +0.0% YoY). Technical & Structure Timing Caution: NMR is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.4); meanwhile GAINZ trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 50.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

NMR leads the Growth & Scale pillar: NMR posts +17.9% YoY revenue growth and +13.6% YoY earnings growth on $14.9B TTM revenue (77.4% gross margin, 25.1% operating margin), compared with GAINZ at +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, NMR generates $14.9B in USD-normalized revenue versus N/A for GAINZ. In operating R&D and SG&A reinvestment, NMR deploys 52.3% of Rev ($7.77B) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for GAINZ.

NMR screens cheaper on headline valuation multiples. NMR trades at 11.4x Forward P/E, 10.4x Trailing P/E, 0.81x PEG, and 1.8x EV/Revenue (unreported cash flow margin), whereas GAINZ trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NMR (11.5% ROE) versus GAINZ (0.0% ROE) capital efficiency.

In options market volatility and institutional positioning, NMR carries 30.7% implied volatility (<1st %ile, Compressed (<25th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.04β · 34% Vol realized risk). By comparison, GAINZ carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.00β · 3% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.